Cargando…

Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy

The use of immune checkpoint inhibitors (ICI) has substantially increased the overall survival of cancer patients and has revolutionized the therapeutic situation in oncology. However, not all patients and cancer types respond to ICI, or become resistant over time. Combining ICIs with therapeutic ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nasti, Tahseen H., Eberhardt, Christiane S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706349/ https://www.ncbi.nlm.nih.gov/pubmed/34960142 http://dx.doi.org/10.3390/vaccines9121396

Ejemplares similares

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade
por: Gong, Jun, et al.
Publicado: (2018)

Vaccines against Infectious Diseases and Cancer
por: Sousa, Ângela, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022)

Anti-Infectious Agents against MRSA
por: Koyama, Nobuhiro, et al.
Publicado: (2012)

Immune checkpoint inhibitors in cancer therapy
por: Webb, Eika S., et al.
Publicado: (2018)

Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors
por: Karaki, Soumaya, et al.
Publicado: (2016)

Fueling the engine and releasing the break: combinational therapy of cancer vaccines and immune checkpoint inhibitors
por: Kleponis, Jennifer, et al.
Publicado: (2015)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
por: Lee, Juwon, et al.
Publicado: (2021)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
por: Basudan, Ahmed M.
Publicado: (2022)

Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
por: Ciciola, Paola, et al.
Publicado: (2020)

Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis
por: Worm, Margitta, et al.
Publicado: (2023)

Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
por: Brüstle, Karina, et al.
Publicado: (2017)

Combining checkpoint inhibitors and BRAF-targeted agents against metastatic melanoma
por: Cooper, Zachary A., et al.
Publicado: (2013)

Cancer vaccine: learning lessons from immune checkpoint inhibitors
por: Ye, ZhenLong, et al.
Publicado: (2018)

Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
por: Repáraz, David, et al.
Publicado: (2022)

Checkpoint inhibitor/interleukin‐based combination therapy of cancer
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors
por: Zhang, Xin, et al.
Publicado: (2022)

Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
por: Buchwald, Zachary S, et al.
Publicado: (2020)

New biomarkers for checkpoint inhibitor therapy
por: Burdett, Nikki, et al.
Publicado: (2020)

Correction: Checkpoint inhibitor induced cardiotoxicity: managing the drawbacks of our newest agents against cancer
por: Brüstle, Karina, et al.
Publicado: (2018)

Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota
por: Frankel, Arthur E., et al.
Publicado: (2019)

Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy
por: ISHIKAWA, Eiichi, et al.
Publicado: (2017)

Noninvasive vaccination against infectious diseases
por: Zheng, Zhichao, et al.
Publicado: (2018)

Checkpoint Inhibitors in Cancer Therapy: Clinical Benefits for Head and Neck Cancers
por: Ettl, Tobias, et al.
Publicado: (2022)

Microbial biomarkers for immune checkpoint blockade therapy against cancer
por: Adachi, Keishi, et al.
Publicado: (2018)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
por: Buchwald, Zachary S., et al.
Publicado: (2018)

Immune Checkpoint Inhibitor Therapy Associated Hypophysitis
por: Mahzari, Moeber, et al.
Publicado: (2015)

The role of infectious agents in urogenital cancers
por: Alibek, Kenneth, et al.
Publicado: (2012)

Immunotherapy and vaccination against infectious diseases
por: Ebbers, Meinolf, et al.
Publicado: (2020)

Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy
por: Jella, Kishore Kumar, et al.
Publicado: (2018)

Immune checkpoint inhibitor combination therapy for gastric cancer: Research progress
por: Song, Xiaoxu, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Cancer Therapy—How to Overcome Drug Resistance?
por: Lao, Yefang, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Based Combination Therapy for Colorectal Cancer: An Overview
por: Li, Jingjing, et al.
Publicado: (2023)

Advances in immune checkpoint inhibitors therapy for small cell lung cancer
por: Li, Longhui, et al.
Publicado: (2023)

Molecular imaging biomarkers for immune checkpoint inhibitor therapy
por: van de Donk, Pim P, et al.
Publicado: (2020)

Combination therapy of cancer with cancer vaccine and immune checkpoint inhibitors: A mathematical model
por: Lai, Xiulan, et al.
Publicado: (2017)

Infectious complications of immune checkpoint inhibitors in solid organ malignancies
por: Ross, Justine Abella, et al.
Publicado: (2021)

Checkpoint Inhibitors and Hepatotoxicity
por: Malnick, Stephen D. H., et al.
Publicado: (2021)

mRNA mediates passive vaccination against infectious agents, toxins, and tumors
por: Thran, Moritz, et al.
Publicado: (2017)

Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination
por: Reens, Abigail L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4u5h652qql83h8iq715es5kqpk